Macatangay BJ - Search Results

1

Persistence of a Skewed Repertoire of NK Cells in People with HIV-1 on Long-Term Antiretroviral Therapy.

Anderko RR, DePuyt AE, Bronson R, Bullotta AC, Aga E, Bosch RJ, Jones RB, Eron JJ, Mellors JW, Gandhi RT, McMahon DK, Macatangay BJ, Rinaldo CR, Mailliard RB. Anderko RR, et al. Among authors: macatangay bj. J Immunol. 2024 May 15;212(10):1564-1578. doi: 10.4049/jimmunol.2300672. J Immunol. 2024. PMID: 38551350

2

Regulatory T cell suppression of Gag-specific CD8 T cell polyfunctional response after therapeutic vaccination of HIV-1-infected patients on ART.

Macatangay BJ, Szajnik ME, Whiteside TL, Riddler SA, Rinaldo CR. Macatangay BJ, et al. PLoS One. 2010 Mar 24;5(3):e9852. doi: 10.1371/journal.pone.0009852. PLoS One. 2010. PMID: 20352042 Free PMC article.

3

PD-1 blockade: A promising immunotherapy for HIV?

Macatangay BJ, Rinaldo CR. Macatangay BJ, et al. Cellscience. 2009 Apr 27;5(4):61-65. Cellscience. 2009. PMID: 20490361 Free PMC article.

4

Comparison of immunologic assays for detecting immune responses in HIV immunotherapeutic studies: AIDS Clinical Trials Group Trial A5181.

Macatangay BJ, Zheng L, Rinaldo CR, Landay AL, Pollard RB, Pahwa S, Lederman MM, Bucy RP. Macatangay BJ, et al. Clin Vaccine Immunol. 2010 Sep;17(9):1452-9. doi: 10.1128/CVI.00498-09. Epub 2010 Jul 14. Clin Vaccine Immunol. 2010. PMID: 20631337 Free PMC article.

5

Regulatory T cells in HIV immunotherapy.

Macatangay BJ, Rinaldo CR. Macatangay BJ, et al. HIV Ther. 2010 Nov;4(6):639-647. doi: 10.2217/hiv.10.51. HIV Ther. 2010. PMID: 21461400 Free PMC article.

6

MDSC: a new player in HIV immunopathogenesis.

Macatangay BJ, Landay AL, Rinaldo CR. Macatangay BJ, et al. AIDS. 2012 Jul 31;26(12):1567-9. doi: 10.1097/QAD.0b013e328355e682. AIDS. 2012. PMID: 22810370 Free PMC article. No abstract available.

7

CD4⁺CD73⁺ T cells are associated with lower T-cell activation and C reactive protein levels and are depleted in HIV-1 infection regardless of viral suppression.

Schuler PJ, Macatangay BJ, Saze Z, Jackson EK, Riddler SA, Buchanan WG, Hilldorfer BB, Mellors JW, Whiteside TL, Rinaldo CR. Schuler PJ, et al. Among authors: macatangay bj. AIDS. 2013 Jun 19;27(10):1545-55. doi: 10.1097/QAD.0b013e328360c7f3. AIDS. 2013. PMID: 24005375 Free PMC article.

8

Increases in duration of first highly active antiretroviral therapy over time (1996-2009) and associated factors in the Multicenter AIDS Cohort Study.

Slama L, Li X, Brown T, Jacobson LP, Pialoux G, Macatangay B, Bolan RK, Phair J, Palella FJ Jr; Multicenter AIDS cohort Study. Slama L, et al. J Acquir Immune Defic Syndr. 2014 Jan 1;65(1):57-64. doi: 10.1097/QAI.0b013e3182a99a0d. J Acquir Immune Defic Syndr. 2014. PMID: 24419062 Free PMC article.

9

Rifaximin has a marginal impact on microbial translocation, T-cell activation and inflammation in HIV-positive immune non-responders to antiretroviral therapy - ACTG A5286.

Tenorio AR, Chan ES, Bosch RJ, Macatangay BJ, Read SW, Yesmin S, Taiwo B, Margolis DM, Jacobson JM, Landay AL, Wilson CC; A5286 Team. Tenorio AR, et al. Among authors: macatangay bj. J Infect Dis. 2015 Mar 1;211(5):780-90. doi: 10.1093/infdis/jiu515. Epub 2014 Sep 11. J Infect Dis. 2015. PMID: 25214516 Free PMC article. Clinical Trial.

10

Preserving HIV-specific T cell responses: does timing of antiretroviral therapy help?

Macatangay BJ, Rinaldo CR. Macatangay BJ, et al. Curr Opin HIV AIDS. 2015 Jan;10(1):55-60. doi: 10.1097/COH.0000000000000124. Curr Opin HIV AIDS. 2015. PMID: 25389805 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

71 results

Search Page